[go: up one dir, main page]

About: John E. Niederhuber

An Entity of Type: person, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI),from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.

thumbnail
Property Value
dbo:abstract
  • John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI),from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network. (en)
dbo:thumbnail
dbo:wikiPageID
  • 25019076 (xsd:integer)
dbo:wikiPageLength
  • 10525 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1097403485 (xsd:integer)
dbo:wikiPageWikiLink
dbp:date
  • November 2018 (en)
dbp:order
  • 13 (xsd:integer)
dbp:reason
  • Please rephrase to clarify whether it was Andrew von Eschenbach or John Niederhuber who went on to the Director of Biotechnology position at BioTime. (en)
dbp:title
  • Director of the National Cancer Institute (en)
dbp:wikiPageUsesTemplate
dbp:years
  • 2006 (xsd:integer)
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI),from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network. (en)
rdfs:label
  • John E. Niederhuber (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:doctoralAdvisor of
is dbo:predecessor of
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is dbp:doctoralAdvisor of
is dbp:predecessor of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License